Opioid Addiction Indication Could Offer Fix For Alkermes' Troubled Vivitrol
• By The Pink Sheet
Alkermes' four-year-old Vivitrol has been struggling to get its head above water as a therapy for alcoholism. But fast-track status for a new opioid addiction indication and a slew of supportive studies at the American Psychiatric Association meeting offer the $900-a-month injectable a shot at recovery
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
